Cat. No. | Product name | CAS No. |
DCS-114 |
Embelin
>98%,Standard References |
550-24-3 |
DC11695 |
AT-IAP
A potent, orally bioavailable, dual XIAP/cIAP1 inhibitor with EC50 of 5.1/0.32 nM, respectively. |
1403898-55-4 |
DC8232 |
AZD5582
Featured
AZD5582 is a novel class of dimeric Smac mimetics as potent IAP antagonist; binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC50 = 15, 21, and 15 nM, respectively). |
1258392-53-8 |
DC7563 |
BV6
Featured
BV6 induced apoptotic and necrotic cell death in monocytes while T-cells, dendritic cells and macrophages were largely protected against BV6-induced cell death. |
1001600-56-1 |
DC4119 |
YM155
Featured
YM155 is a potent IAP (inhibitor of apoptosis proteins) inhibitor for survivin with IC50 of 0.54 nM. |
781661-94-7 |
DC42284 |
APG-1387
APG-1387, a bivalent SMAC mimetic, is an IAP antagonist that can induce proteasomal degradation of IAPs. APG-1387 sensitizes immune-mediated cell apoptosis in cancers. APG-1387 can be used for the research of hepatocellular carcinoma, ovarian cancer, and nasopharyngeal carcinoma. |
1570231-89-8 |